India, July 24 -- Riding on policy reforms that earned it the top rank among large states in NITI Aayog's Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received pharmaceutical investment proposals worth Rs 992.53 crore over the past 18 months under its Industrial Development Policy 2024-30, with four projects worth Rs 216 crore already under implementation, signalling that investor interest is translating into on-ground manufacturing activity.

The four projects, being developed by 9M India, Shankara Latex Industries, Avila Pharmaceuticals and Vitalis Health Services, are at various stages of implementation.

Facilities by 9M India and Shankara Latex Industries are under constructio...